Fosun International LTD Vbi Vaccines Inc Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$0.47 - $1.05 $494,029 - $1.1 Million	-1,051,126 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$0.65 - $2.12 $207,379 - $676,375	319,045 Added 43.58%	1,051,126 $1.16 Million
Q1 2019 May 10, 2019	BUY	$1.54 - $2.01 $133,980 - $174,869	87,000 Added 13.49%	732,081 $1.37 Million
Q4 2018 Jan 31, 2019	BUY	$1.22 - $2.41 $786,998 - $1.55 Million	645,081 New	645,081 $935,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.